Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers
The management of advanced gynecologic cancers remains a challenge, but the treatment landscape is changing.
Gynecologic, Ovarian, and Cervical Cancer News
GYNECOLOGIC CANCER ADVISOR
Vistusertib Provides No Benefit in Platinum-Resistant/Refractory Ovarian Cancer
Adding vistusertib to treatment with paclitaxel does not improve outcomes in patients with platinum-resistant or -refractory ovarian cancer, a phase 2 trial suggests.
Postoperative AEs Delay Chemotherapy but Do Not Affect Survival in Ovarian Cancer
Postoperative adverse events can delay chemotherapy but do not affect survival outcomes in patients with platinum-sensitive, recurrent ovarian cancer, a study suggests.
Initiative Increased BRCA Testing in Ovarian Cancer Patients
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
Insurance Status Mediates Racial, Ethnic Inequities in Cervical Cancer
A larger proportion of patients with private or Medicare insurance received a diagnosis of early-stage cervical cancer.
Women With BRCA1/2 Mutations Have High Risk of Cancer After Age 50
The risk of cancer remains high for women older than 50 years with BRCA1 or BRCA2 mutations, a study suggests.
Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, a study suggests.
Cardiovascular Risk Stratification for Older Adults Undergoing Cancer Surgery
Identifying limitations in functional reserves in the older adult leads to improved decision-making related to cardiovascular risk stratification and elective procedures.
Most Quality Metrics for Cancer Screening Tests Are Not Supported by Evidence
Quality metrics for cancer screening tests vary across cancer types, but most metrics are not supported by evidence, a study suggests.
Jemperli Granted Full Approval for dMMR Recurrent or Advanced Endometrial Cancer
The accelerated approval for Jemperli (dostarlimab-gxly) was converted to regular approval.
Mirvetuximab Soravtansine Could Be New Standard Care for Platinum-Resistant Ovarian Cancer
Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.
Cancer Mortality Rates Increased for Older Patients With Diabetes
People with type 2 diabetes have an increased risk of death from colorectal, pancreatic, liver, and endometrial cancer, compared with the general population.
Ultra-Processed Food Linked to Increased Risk of Cancer and Death
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
Experts Say Even Low-Risk Patients Should Remove Fallopian Tubes to Avoid Cancer
More patients should consider having their fallopian tubes removed to prevent ovarian cancer, according to the Ovarian Cancer Research Alliance.
Purchasing Data Could Be Used to Predict Ovarian Cancer, Researchers Say
Purchases of over-the-counter pain and indigestion medications could be used to predict ovarian cancer months before diagnosis, a study suggests.
Declining Physical Function Is Accelerated Among Postmenopausal Cancer Survivors
Postmenopausal cancer survivors have greater declines in physical function than cancer-free control individuals, a new study suggests.
Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Patients 65 and Older More Likely to Have Late-Stage Cervical Cancer
Patients age 65 and older are more likely to be diagnosed with late-stage cervical cancer and have a lower rate of late-stage survival at 5 years.
Risk of Sexual Dysfunction Higher for Survivors of Gynecologic Cancers
Compared with the general population, survivors of gynecologic cancers have a higher risk of sexual dysfunction 1 to 5 years after cancer diagnosis.
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Gynecologic Cancer
Loading... 
Loading...